Table of Contents
ISRN Urology
Volume 2012 (2012), Article ID 759258, 7 pages
http://dx.doi.org/10.5402/2012/759258
Research Article

The Impact of Financial Interest in Intensity-Modulated Radiation Therapy on the Utilization of Radiation Therapy for Treatment of Newly Diagnosed Prostate Cancer: A Single Center Experience

The Bryn Mawr Urology Group, Academic Urology, Bryn Mawr, PA 19010, USA

Received 28 November 2011; Accepted 28 December 2011

Academic Editors: T. Nishiyama and R. Schiavina

Copyright © 2012 Xiaolong S. Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Siegel, E. Ward, O. Brawley, and A. Jemal, “Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths,” CA Cancer Journal for Clinicians, vol. 61, no. 4, pp. 212–236, 2011. View at Publisher · View at Google Scholar · View at PubMed
  2. M. Center, R. Siegel, and J. Ahmedin, Global Cancer Facts & Figures, American Cancer Society, Atlanta, Ga, USA, 2nd edition, 2011.
  3. M. S. Anscher, B. M. Anscher, and C. J. Bradley, “The negative impact of stark law exemptions on graduate medical education and health care costs: the example of radiation oncology,” International Journal of Radiation Oncology Biology Physics, vol. 76, no. 5, pp. 1289–1294, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. B. P. Falit, C. P. Gross, and K. B. Roberts, “Integrated prostate cancer centers and Over-utilization of IMRT: a close look at fee-for-service medicine in radiation oncology,” International Journal of Radiation Oncology Biology Physics, vol. 76, no. 5, pp. 1285–1288, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. A. Al-Mamgani, W. L. J. van Putten, W. D. Heemsbergen et al., “Update of dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer,” International Journal of Radiation Oncology Biology Physics, vol. 72, no. 4, pp. 980–988, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. D. P. Dearnaley, M. R. Sydes, J. D. Graham et al., “Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial,” Lancet Oncology, vol. 8, no. 6, pp. 475–487, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. A. L. Zietman, M. L. DeSilvio, J. D. Slater et al., “Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial,” Journal of the American Medical Association, vol. 294, no. 10, pp. 1233–1239, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. N. K. Sharma, T. Li, D. Y. Chen, A. Pollack, E. M. Horwitz, and M. K. Buyyounouski, “Intensity-modulated radiotherapy reduces gastrointestinal toxicity in patients treated with androgen deprivation therapy for prostate cancer,” International Journal of Radiation Oncology, Biology, Physics, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. M. J. Zelefsky, H. Chan, M. Hunt, Y. Yamada, A. M. Shippy, and H. Amols, “Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer,” Journal of Urology, vol. 176, no. 4, pp. 1415–1419, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. A. Al-Mamgani, W. D. Heemsbergen, S. T. H. Peeters, and J. V. Lebesque, “Role of intensity-modulated radiotherapy in reducing toxicity in dose escalation for localized prostate cancer,” International Journal of Radiation Oncology Biology Physics, vol. 73, no. 3, pp. 685–691, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. L. Klotz, L. Zhang, A. Lam, R. Nam, A. Mamedov, and A. Loblaw, “Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer,” Journal of Clinical Oncology, vol. 28, no. 1, pp. 126–131, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. J. H. Hayes, D. A. Ollendorf, S. D. Pearson et al., “Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis,” Journal of the American Medical Association, vol. 304, no. 21, pp. 2373–2380, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. M. R. Cooperberg, J. E. Cowan, J. F. Hilton et al., “Outcomes of active surveillance for men with intermediate-risk prostate cancer,” Journal of Clinical Oncology, vol. 29, no. 2, pp. 228–234, 2011. View at Publisher · View at Google Scholar · View at PubMed